Systematic Financial Management LP Sells 1,225 Shares of LHC Group Inc. (LHCG)
Systematic Financial Management LP cut its stake in shares of LHC Group Inc. (NASDAQ:LHCG) by 2.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,921 shares of the company’s stock after selling 1,225 shares during the period. Systematic Financial Management LP owned about 0.24% of LHC Group worth $1,857,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. increased its stake in LHC Group by 8.2% in the second quarter. Ameriprise Financial Inc. now owns 516,917 shares of the company’s stock worth $22,372,000 after buying an additional 39,289 shares during the last quarter. Rothschild Asset Management Inc. increased its stake in LHC Group by 26.6% in the second quarter. Rothschild Asset Management Inc. now owns 371,297 shares of the company’s stock worth $16,070,000 after buying an additional 77,994 shares during the last quarter. State Street Corp increased its stake in LHC Group by 3.7% in the first quarter. State Street Corp now owns 348,855 shares of the company’s stock worth $12,406,000 after buying an additional 12,414 shares during the last quarter. Norges Bank bought a new stake in LHC Group during the fourth quarter worth $11,656,000. Finally, Boston Partners increased its stake in LHC Group by 7.6% in the second quarter. Boston Partners now owns 192,298 shares of the company’s stock worth $8,323,000 after buying an additional 13,628 shares during the last quarter. Institutional investors and hedge funds own 80.71% of the company’s stock.
LHC Group Inc. (NASDAQ:LHCG) traded down 1.462% during midday trading on Tuesday, hitting $36.055. The company’s stock had a trading volume of 22,904 shares. The company has a market cap of $654.51 million, a PE ratio of 18.877 and a beta of 0.78. LHC Group Inc. has a 52-week low of $32.77 and a 52-week high of $50.68. The stock has a 50 day moving average of $37.82 and a 200 day moving average of $39.88.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.52 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.52. LHC Group had a return on equity of 9.64% and a net margin of 3.87%. The firm earned $226 million during the quarter, compared to analyst estimates of $221.09 million. During the same period last year, the company earned $0.51 earnings per share. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities analysts expect that LHC Group Inc. will post $1.99 EPS for the current year.
A number of research firms have recently commented on LHCG. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $46.00 price target (down previously from $50.00) on shares of LHC Group in a report on Tuesday, September 13th. Stephens began coverage on LHC Group in a report on Friday, June 17th. They set an “overweight” rating and a $55.00 price target for the company. Finally, Zacks Investment Research cut LHC Group from a “buy” rating to a “sell” rating in a report on Tuesday, August 9th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $47.71.
In related news, Director Kenneth E. Thorpe sold 1,450 shares of LHC Group stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $36.88, for a total transaction of $53,476.00. Following the completion of the sale, the director now owns 17,550 shares of the company’s stock, valued at $647,244. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 18.30% of the stock is owned by insiders.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.